Targeting Cell Senescence to Prevent Age-Related Diseases

Senescence2030 is a new COST Action fostering dynamic knowledge exchange on senescence and senotherapy. We connect basic scientists, clinicians, and stakeholders to bridge the gap between research and clinical application in Europe. Our goal is to accelerate the development of effective diagnostics, clinical trials, and interventions in lifestyle and nutrition that target senescence.

While Senescence2030 is just getting started, we’re excited to share our progress. This website is currently under construction, with a full launch planned for this summer. In the meantime, you can find here information about our activities and how to get involved.